Search for a clinical trial
Other search option(s)
8 Result(s)
Recruiting trial
= 
; Ongoing trial
= 
; Terminated trial = 
; Funded by an IRDiRC member = 
; Study involving ERN members in at least two Member States = 
National clinical trial(s)
FRANCE
HAUTS-DE-FRANCE
ADDRESS: NOT PROVIDED - FR
A Randomised, Controlled, Multidose, Multicentre, Adaptive Phase II/III Study in Infants With Proliferating Infantile Hemangiomas (IHs) Requiring Systemic Therapy to Compare 4 Regimens of Propranolol (1 or 3 mg/kg/Day for 3 or 6 Months) to Placebo (Double Blind) - FR
Institution: Information not provided - FR
GERMANY
Berlin
BERLIN
ROPROP: Oral Propranolol for prevention of thresholdretinopathy of prematurity - DE
Charité - Universitätsmedizin Berlin (CCM)
Klinik für Neonatologie
GERMANY
Nordrhein-Westfalen
KÖLN
METRO-NB 2012: Phase II trial of metronomic treatment in children and adolescents with recurrent or progressive neuroblastoma - DE
Universitätsklinikum Köln
Pädiatrische Onkologie und Hämatologie
ITALY
TOSCANA
FIRENZE
Safety and efficacy of treatment with propranolol in newborns suffering from rethinopathy of the preterm: a pilot study
Azienda Ospedaliera Universitaria Anna Meyer I.R.C.C.S.
Terapia Intensiva Neonatale
ITALY
TOSCANA
FIRENZE
Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Newborn With Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%)
Azienda Ospedaliera Universitaria Anna Meyer I.R.C.C.S.
Terapia Intensiva Neonatale
NETHERLANDS
Noord-Holland
AMSTERDAM
PropAngio study: Neoadjuvant Trial on the Efficacy of Propranolol Monotherapy in Cutaneous Angiosarcoma
Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
Afdeling Medische Oncologie
SPAIN
Castilla - La Mancha
TOLEDO
Therapeutic effect of propranolol in a series of patients with von Hippel-Lindau disease and retinal hemangioblastomas in short, medium and long term treatment - ES (Completed)
Hospital Virgen de la Salud
Servicio de Oftalmología
SWITZERLAND
Suisse Alémanique
ZÜRICH